The European Commission is taking a look at prostaglandins and their analogues in cosmetic products, noting safety concerns and findings of uneven regulatory application across EU member states.
Announced on 22 June, the Commission will request a safety opinion on prostaglandins and their analogues from the Scientific Committee...







